Calamos Advisors’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-292,426
Closed -$5.33M 1197
2025
Q4
$5.33M Buy
292,426
+159,501
+120% +$2.69M 0.02% 517
2025
Q3
$1.95M Sell
132,925
-404,395
-75% -$6.93M 0.01% 633
2025
Q2
$9.78M Buy
537,320
+3,483
+0.7% +$71K 0.04% 411
2025
Q1
$10.6M Buy
533,837
+107,931
+25% +$1.87M 0.05% 379
2024
Q4
$7.3M Buy
425,906
+28,154
+7% +$530K 0.03% 459
2024
Q3
$7.95M Sell
397,752
-205,251
-34% -$3.19M 0.04% 461
2024
Q2
$6.74M Buy
603,003
+46,405
+8% +$389K 0.03% 476
2024
Q1
$3.67M Buy
556,598
+306,413
+122% +$1.67M 0.02% 531
2023
Q4
$1.13M Buy
250,185
+137,749
+123% +$510K 0.01% 657
2023
Q3
$403K Buy
112,436
+55,212
+96% +$213K ﹤0.01% 724
2023
Q2
$211K Buy
+57,224
New +$212K ﹤0.01% 784

Other funds holding ADMA